Overview

Azithromycin in the Treatment of Cryptosporidiosis in Patients Who Have Not Had Success With Other Drugs

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To provide azithromycin for the treatment of individual patients with proven cryptosporidiosis whose disease has persisted or progressed despite prior therapies.
Phase:
N/A
Details
Lead Sponsor:
Pfizer
Treatments:
Azithromycin